Nuclear Medicine: Page 33

FDA clears Cardinal's Lymphoseek for pediatric use

By AuntMinnie.com staff writers

Cardinal Health announced that its Lymphoseek radiopharmaceutical has been approved for pediatric use by the U.S. Food and Drug Administration (FDA).

June 10, 2021

SNMMI pushes for coverage of PET tracers for Aduhelm use

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced it will leverage the recent approval of Biogen's aducanumab (Aduhelm) drug for treating Alzheimer's disease to lobby the U.S. Centers for Medicare and Medicaid Services to reimburse beta amyloid PET imaging.

June 9, 2021

FDG-PET lymph node uptake after COVID-19 vaccines mimics cancer

By Will Morton

Abnormal PET radiotracer uptake in lymph nodes that can mimic malignant cancer is more common in patients who have had the second dose of the Moderna COVID-19 vaccine, according to research published June 10 in JAMA Oncology.

June 9, 2021

AI classifies severity of Parkinson's on 3D SPECT

By Erik L. Ridley

Artificial intelligence (AI)-based analysis of 3D SPECT exams can help physicians to determine a patient's stage of Parkinson's disease, according to research published online May 30 in Expert Systems and Applications.

June 9, 2021

Shine signs deal with MURR

By AuntMinnie.com staff writers

Shine Medical Technologies has signed a multiyear deal with the University of Missouri Research Reactor (MURR) covering the production of the precursor isotope to lutetium-177, a radioisotope used for therapeutic applications.

June 8, 2021

Biodex to lay off a third of employees

By AuntMinnie.com staff writers

Medical imaging accessory supplier Biodex Medical Systems plans to lay off about a third of its nonunion employees, according to a report filed last month with the state's labor department.

June 7, 2021

Novartis touts prostate cancer study results at ASCO 2021

By AuntMinnie.com staff writers

Novartis highlighted results presented at the virtual American Society of Clinical Oncology meeting that suggest lutetium-177 prostate-specific membrane antigen-617 is safe and effective for patients with PSMA-positive metastatic prostate cancer.

June 7, 2021

Physicists want ban on radioactive alternative medicine pendants

By Will Morton

A group of Malaysian physicists are recommending a ban on so-called "scalar energy" pendants after finding that the alternative medicine trinkets are actually embedded with radioactive isotopes, according to a study published June 1 in Plos One.

June 6, 2021

SNMMI offers letter to contest SPECT/CT denials

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published a letter template for healthcare providers to use to contest coverage denials of SPECT/CT exams.

June 2, 2021

ImaginAb lands $13M in growth funding

By AuntMinnie.com staff writers

Radiopharmaceutical developer ImaginAb has raised almost $13 million in funding to support the company's growth and further development of its CD8 Immuno-PET agent.

June 2, 2021

Fusion Pharmaceuticals to build radiopharma plant in Canada

By AuntMinnie.com staff writers

McMaster University spin-off company Fusion Pharmaceuticals announced it has entered a 15-year lease agreement with the school for a new manufacturing facility for therapeutic pharmaceuticals near its campus in Hamilton, Ontario.

June 2, 2021

'Early frame' PET may reduce cost and burden in Alzheimer's disease

By Will Morton

PET imaging of patients to detect Alzheimer's disease may be effective in minutes rather than hours after they are injected with a radiotracer, according to research published May 28 in the Journal of Nuclear Medicine. The finding suggests "early frame" PET may reduce imaging costs and burden on patients and their families.

June 1, 2021

Previous Page

Page 33 of 438

Next Page